Form 8-K - Current report:
SEC Accession No. 0001193125-22-084001
Filing Date
2022-03-24
Accepted
2022-03-24 17:13:17
Documents
13
Period of Report
2022-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d329372d8k.htm   iXBRL 8-K 25310
2 EX-99.1 d329372dex991.htm EX-99.1 57853
  Complete submission text file 0001193125-22-084001.txt   209208

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA neog-20220324.xsd EX-101.SCH 2842
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20220324_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20220324_pre.xml EX-101.PRE 10803
7 EXTRACTED XBRL INSTANCE DOCUMENT d329372d8k_htm.xml XML 3256
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 22767422
SIC: 2835 In Vitro & In Vivo Diagnostic Substances